Changes in quality of life of early-stage lung cancer patients undergoing sublobar resection: a systematic review

被引：0
作者：
Magouliotis, Dimitrios E. [1 ]
Cioffi, Ugo [2 ]
Minervini, Fabrizio [3 ]
Lampridis, Savvas [4 ]
Guttadauro, Angelo [2 ]
Scarci, Marco [5 ]
机构：
[1] Lankenau Inst Med Res, Dept Cardiac Surg Res, Wynnewood, PA USA
[2] Univ Milan, Dept Surg, Milan, Italy
[3] Cantonal Hosp Lucerne, Div Thorac Surg, Luzern, Switzerland
[4] 424 Gen Mil Hosp, Dept Thorac Surg, Thessaloniki, Greece
[5] Hammersmith Hosp, Imperial Coll Healthcare, Dept Cardiothorac Surg, Natl Hlth Serv NHS Trust, London, England
来源：
FRONTIERS IN SURGERY | 2025年 / 12卷
关键词：
quality of life; sublobar lung resection; lobectomy; lung cancer; stereotactic body radiotherapy (SBRT); HEALTH SURVEY; LOBECTOMY; RADIOTHERAPY; RELIABILITY; VALIDITY;
D O I：
10.3389/fsurg.2025.1542036
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Objective: This systematic review aimed to evaluate the impact of sublobar resection (SLR) on the quality of life (QoL) of patients with early-stage non-small cell lung cancer (NSCLC). Specifically, it compared outcomes between sublobar resection, lobectomy, and stereotactic body radiation therapy (SBRT). Methods: A literature search was conducted across PubMed and Scopus, identifying studies published from 2010 to 2024 that reported QOL outcomes in early-stage NSCLC patients treated with lobectomy, SLR, or SBRT. Inclusion criteria were studies with more than 10 patients, written in English, and using validated QoL metrics. Data on demographics, interventions, QoL tools, and findings were extracted, and study quality was assessed using the Newcastle-Ottawa Scale and the ROBINS-I tool. Results: Five studies involving 1,149 patients from six countries met the inclusion criteria. QoL outcomes consistently favored SLR over lobectomy in domains such as physical and respiratory function, with SLR patients experiencing faster recovery and fewer complications. Minimally invasive techniques, such as video-assisted thoracoscopic surgery (VATS), further enhanced these outcomes. SBRT demonstrated stable QOL post-treatment but lacked the long-term physical recovery benefits observed with SLR. Commonly employed QoL tools included the EORTC QLQ-C30, Leicester Cough Questionnaire, and NSCLC-PQOL, each capturing distinct dimensions of patient QoL status. Conclusion: Sublobar resection provides significant QoL benefits for selected early-stage NSCLC patients compared to lobectomy, particularly in respiratory health and recovery endpoints. These findings highlight the value of personalized surgical approaches and the need for further research on optimizing QoL in NSCLC management.
引用
收藏
页数：10
相关论文
共 33 条
  • [1] Siegel R.L., Miller K.D., Jemal A., Cancer statistics, 2020, CA Cancer J Clin, 70, 1, pp. 7-30, (2020)
  • [2] Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, 5, pp. 395-409, (2011)
  • [3] Mazzone P.J., Silvestri G.A., Souter L.H., Caverly T.J., Kanne J.P., Katki H.A., Et al., Screening for lung cancer: CHEST guideline and expert panel report, Chest, 160, 4, pp. e427-e494, (2021)
  • [4] Detterbeck F.C., Boffa D.J., Kim A.W., Tanoue L.T., The eighth edition lung cancer stage classification, Chest, 151, 1, pp. 193-203, (2017)
  • [5] Howlader N., Forjaz G., Mooradian M.J., Meza R., Kong C.Y., Cronin K.A., Et al., The effect of advances in lung-cancer treatment on population mortality, N Engl J Med, 383, 7, pp. 640-649, (2020)
  • [6] Altorki N.K., Yip R., Hanaoka T., Bauer T., Aye R., Kohman L., Et al., Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules, J Thorac Cardiovasc Surg, 147, 2, pp. 754-762, (2014)
  • [7] Ginsberg R.J., Rubinstein L.V., Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer, Ann Thorac Surg, 60, 3, pp. 615-623, (1995)
  • [8] Chang J.Y., Senan S., Paul M.A., Mehran R.J., Louie A.V., Balter P., Et al., Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomized trials, Lancet Oncol, 16, 6, pp. 630-637, (2015)
  • [9] Ezer N., Veluswamy R.R., Mhango G., Rosenzweig K.E., Powell C.A., Wisnivesky J.P., Outcomes after stereotactic body radiotherapy versus limited resection in older patients with early-stage lung cancer, J Thorac Oncol, 10, pp. 1201-1206
  • [10] Yang P., Cheville A.L., Wampfler J.A., Garces Y.I., Jatoi A., Clark M.M., Et al., Quality of life and symptom burden among long-term lung cancer survivors, J Thorac Oncol, 7, 1, pp. 64-70, (2012)
1234